Ward, K. E.; Archambault, R.; Mersfelder, T. L. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. American Journal of Health-System Pharmacy. 2010, 67 (3): 206–213. PMID 20101062. doi:10.2146/ajhp080603.
Chung WH, Hung SI, Hong HS; et al. Medical genetics: a marker for Stevens–Johnson syndrome. Nature. April 2004, 428 (6982): 486. PMID 15057820. doi:10.1038/428486a. 引文格式1维护:显式使用等标签 (link)
Locharernkul C, Loplumlert J, Limotai C; et al. Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. July 2008, 49 (12): 2087. PMID 18637831. doi:10.1111/j.1528-1167.2008.01719.x. 引文格式1维护:显式使用等标签 (link)
Man CB, Kwan P, Baum L; et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia. May 2007, 48 (5): 1015–8. PMID 17509004. doi:10.1111/j.1528-1167.2007.01022.x. 引文格式1维护:显式使用等标签 (link)
Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics. September 2006, 7 (6): 813–8. PMID 16981842. doi:10.2217/14622416.7.6.813.
Lonjou C, Thomas L, Borot N; et al. A marker for Stevens–Johnson syndrome ...: ethnicity matters. Pharmacogenomics J. 2006, 6 (4): 265–8. PMID 16415921. doi:10.1038/sj.tpj.6500356. 引文格式1维护:显式使用等标签 (link)
Lonjou C, Borot N, Sekula P; et al. A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet. Genomics. February 2008, 18 (2): 99–107. PMID 18192896. doi:10.1097/FPC.0b013e3282f3ef9c. 引文格式1维护:显式使用等标签 (link)
emedicine.com
C Stephen Foster, MD, FACS, FACR, FAAO,"Stevens-Johnson Syndrome "[2] (页面存档备份,存于互联网档案馆),Today on Medscape.
Ward, K. E.; Archambault, R.; Mersfelder, T. L. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. American Journal of Health-System Pharmacy. 2010, 67 (3): 206–213. PMID 20101062. doi:10.2146/ajhp080603.
Ikeda Y, Nakajima T.,"Burst digital correlator as laser-Doppler velocimetry signal processor."[1],Appl Opt. 1996 Jun 20;35(18):3243-9. doi: 10.1364/AO.35.003243.
Chung WH, Hung SI, Hong HS; et al. Medical genetics: a marker for Stevens–Johnson syndrome. Nature. April 2004, 428 (6982): 486. PMID 15057820. doi:10.1038/428486a. 引文格式1维护:显式使用等标签 (link)
Locharernkul C, Loplumlert J, Limotai C; et al. Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. July 2008, 49 (12): 2087. PMID 18637831. doi:10.1111/j.1528-1167.2008.01719.x. 引文格式1维护:显式使用等标签 (link)
Man CB, Kwan P, Baum L; et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia. May 2007, 48 (5): 1015–8. PMID 17509004. doi:10.1111/j.1528-1167.2007.01022.x. 引文格式1维护:显式使用等标签 (link)
Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics. September 2006, 7 (6): 813–8. PMID 16981842. doi:10.2217/14622416.7.6.813.
Lonjou C, Thomas L, Borot N; et al. A marker for Stevens–Johnson syndrome ...: ethnicity matters. Pharmacogenomics J. 2006, 6 (4): 265–8. PMID 16415921. doi:10.1038/sj.tpj.6500356. 引文格式1维护:显式使用等标签 (link)
Lonjou C, Borot N, Sekula P; et al. A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet. Genomics. February 2008, 18 (2): 99–107. PMID 18192896. doi:10.1097/FPC.0b013e3282f3ef9c. 引文格式1维护:显式使用等标签 (link)